
OLD Category: FFPE
February 19, 2021 / J Immunother Cancer
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
February 17, 2021 / Front Immunol
A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis
February 12, 2021 / NPJ Breast Cancer
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
February 12, 2021 / NPJ Precis Oncol
Clinical implications of systemic and local immune responses in human angiosarcoma
February 11, 2021 / AJNR Am J Neuroradiol
Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of BRAF-Mutated and BRAF-Fused Tumors
February 9, 2021 / Cancer Discov
Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition
February 9, 2021 / Pancreatology
Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens
February 9, 2021 / Cancer Discov
Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression
February 4, 2021 / Cancers (Basel)